Motilal Oswal's research report on Laxmi Dental
Laxmi Dental (LAXMIDEN) delivered better-than-expected revenue in 2QFY26, whereas EBITDA and PAT came in lower than expectations. Profitability was impacted by US tariff related policy changes and increased competitive pressure in Bizdent segment. International lab business continues to witness improved traction, led by higher off-take of crown/bridges in new geographies.
Outlook
We reduce our earnings estimates for FY26/FY27/FY28 by 6%/8%/11%, factoring in a prolonged impact of global policies, a gradual uptick in kidz-e-dental business, and a temporary slowdown in Bizdent business. We value LAXMIDEN at 33x 12M forward earnings to arrive at a TP of INR410.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
